Home/Filings/4/0001627223-21-000019
4//SEC Filing

Abbott Matthew S 4

Accession 0001627223-21-000019

CIK 0001627223other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 3:40 PM ET

Size

10.7 KB

Accession

0001627223-21-000019

Insider Transaction Report

Form 4
Period: 2021-03-01
Abbott Matthew S
VP, CAO & Controller
Transactions
  • Tax Payment

    Common Stock

    2021-03-01$24.01/sh581$13,95022,117.067 total
  • Award

    Common Stock

    2021-03-01+1,24923,366.067 total
  • Award

    Common Stock

    2021-03-01+10,41233,778.067 total
  • Award

    Stock Option (Right to Buy)

    2021-03-01+12,26912,269 total
    Exercise: $24.01Exp: 2031-03-01Common Stock (12,269 underlying)
Footnotes (5)
  • [F1]Shares automatically withheld to satisfy tax obligations on vesting restricted stock units. Transaction is exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.
  • [F2]Restricted Stock Unit (RSU) award scheduled to vest in three equal annual installments beginning on March 1, 2022.
  • [F3]Restricted Stock Unit (RSU) award scheduled to vest with respect to 100% of the RSUs, including dividend equivalent units, on March 1, 2024.
  • [F4]Includes directly owned shares, restricted stock units and dividend equivalent units.
  • [F5]These options are scheduled to vest in three equal annual installments beginning on March 1, 2022.

Issuer

Chemours Co

CIK 0001627223

Entity typeother

Related Parties

1
  • filerCIK 0001786056

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 3:40 PM ET
Size
10.7 KB